FindTrial
Sign In

The effects of sympathetic adrenal medullary system (SAM), hypothalamus pituitary adrenal cortex system (HPA) and renin angiotension aldosterone system (RAAS) on blood pressure and islet cell function in diabetes patients

The effects of sympathetic adrenal medullary system (SAM), hypothalamus pituitary adrenal cortex system (HPA) and renin angiotension aldosterone system (RAAS) on blood pressure and islet cell function in diabetes patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047106
Enrollment
Unknown
Registered
2021-06-08
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient meets the diagnostic criteria of diabetes.

Exclusion criteria

Exclusion criteria: 1.Pregnancy, mental and neurological disorders; 2.With acute complications of diabetes mellitus, inflammation, cancer, severe liver or kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
catecholamine;—

Countries

China

Contacts

Public ContactLin Kun

The First Affiliated Hospital of Shantou University Medical College

jornbar@126.com+86 754 88905053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026